Skip to main content

Tag: Ablechild


Diane Nahabedian
(617) 943-3732

Over 4.5 million children nationwide have been diagnosed with attention deficit hyperactivity disorder or ADHD according to a study says an article “Youngest in Class get ADHD Label” published this week in USA Today . Nearly 1 million children may have been misdiagnosed because they were the youngest in their class.

Sheila Matthews, co-founder of AbleChild in Connecticut says, “it is unjustifiable to misdiagnose a million children with ADHD. Psychiatry claims ADHD is a serious disease like cancer, and our schools have become a marketing distribution channel for this false data. The “experts” have compared ADHD to having diabetes and touts the cure as the need for powerful dangerous mind altering drugs. Imagine if a million children were diagnosed with cancer or diabetes and underwent needless treatments. Ablechild wants to know what compensation is planned for these children and their families? In addition, when is the psychiatric industry going to tell the truth about ADHD to parents, and the fact that the diagnosis is not based in any real science, and is not a disease like cancer or a condition like diabetes. It is subjective!”

Patricia Weathers, another co-founder of AbleChild, who has testified before a Congressional subcommittee regarding the use of drugs in the schools explains, “when parents are confronted by a teacher or school psychologist regarding issues like ADHD they often feel frightened and alone, and pressured to drug their children. Frequently, parents recognize their child’s challenging behavior as normal, and may not want to subject their child to the serious risks caused by psychotropic drugs.” Weathers herself was threatened with child protective services as a result of a charge of medical neglect waged at her by her son’s school when she took him off psychiatric drugs that caused him a wide array of side effects.

Matthews and Weathers continuously urge all parents to remember that they are their child’s best advocate, and know their own child best. “We urge all parents to gain an understanding of the real risks of psychological and behavioral testing, labeling and drugging,’ says Matthews.

Unfortunately, school officials place tremendous pressure on parents to not only allow the school to conduct psychological testing on their children but to drug them as well. Parents may not realize that these tests are being used many times as the sole basis for the diagnosis of behavioral issues.

AbleChild, a 501C3 established in the state of New York, works with a team of parents, educators, attorneys and non-pharmaceutical-associated psychologists and psychiatrists who all have experience with the risks of psychotropic drugs and non-drug alternatives. AbleChild is a clearinghouse for objective information regarding ADD, ADHD, and other behavioral issues. All services that they render are free to the public.

The parents who founded this extraordinary organization and all those who work with it have personally suffered battles with their schools to have their children tested and drugged.

“Again,” says Matthews, “drugging a child today may result in serious consequences for that child’s future health.” Weathers adds, “if any parent is confronted with the issue of ADD, ADHD, or other behavioral issues that affect their child, please call us. We will give information that can help each parent make an informed decision. We are not a medical group, but a group of concerned parents who want everyone to make healthy decisions for the children they love.”

Please visit AbleChild at www. and become a friend on our Facebook page, or call us at 203-594-1700.

More Toddlers, Young Children Given Antipsychotics

Researchers question the ‘worrisome’ trend

By Jennifer Thomas, HealthDay Reporter

Source: BusinessWeek

MONDAY, Jan. 4 (HealthDay News) — The rate of children aged 2 to 5 who are given antipsychotic medications has doubled in recent years, a new study has found.

Yet little is known about either the effectiveness or the safety of these powerful psychiatric medications in children this age, said researchers from Columbia University and Rutgers University, who looked at data on more than 1 million children with private health insurance.

Continue reading

Drug Makers Are Advocacy Group’s Biggest Donors

By Gardiner Harris

Source: New York Times

WASHINGTON — A majority of the donations made to the National Alliance on Mental Illness, one of the nation’s most influential disease advocacy groups, have come from drug makers in recent years, according to Congressional investigators.

The alliance, known as NAMI, has long been criticized for coordinating some of its lobbying efforts with drug makers and for pushing legislation that also benefits industry.

Continue reading

Generation of Kids Hooked on Psych Drugs

By Evelyn Pringle


Campbell Brown anchors a daily prime-time news program on CNN. On June 17, 2009, in a segment of the program called the “Great Debate,” the question was, Ritalin, Prozac, Adderall, are we “pushing pills on our kids and raising a generation hooked on meds.”

Featured in the debate were, Kelly O’Meara, author of the book, “Psyched Out: How Psychiatry Sells Mental Illness and Pushes Pills that Kill,” and Dr Charles Sophy, a psychiatrist in private practice in Los Angeles, who serves as medical director of the LA County Department of Children and Family Services. They were each given 30 seconds for an opening statement.

Continue reading

ADHD Drugs Linked to Sudden Death

Some Parents Believe New Study Reinforces Link Between Stimulants, Cardiac Death

Source: Article by Dan Childs and Todd Neale, ABC News

For Ann Hohmann, Oct. 21, 2004, began just about like any other day.

On that morning, the 54-year-old mother of two living in McAllen, Texas, was preparing to take her eldest son to school. She had an early appointment, so her husband, Rick Hohmann, would be dropping off younger son, 14-year-old Matthew, at his school that day.

Continue reading

Are We All Going Mad, Or Are The Experts Crazy?

LA Times Opinion Page

By Stuart A. Kirk, STUART A. KIRK is a professor of social welfare at UCLA. He is the coauthor of “The Selling of DSM” and “Making Us Crazy.” His most recent book is “Mental Disorders in the Social Environment”.

PSYCHIATRIC researchers recently estimated that half of the American population has had or will have a mental disorder at some time in their life. A generation ago, by contrast, only a small percentage of the American population was considered mentally ill. Are we all going mad?

Continue reading

Is Your ADHD Support Group a Front Organization for the Pharmaceutical Industry?

By Richard DeGrandpre, Ph.D.

On May 18, 1999, the New York Times reported that “social phobia ranks today as the third most prevalent psychiatric disorder in the United States……….affecting an estimated 19 million Americans, according to the Anxiety Disorders Association of America. Many are to bashful even to talk to therapists.” In the same week, the Boston Globe reported that “Epidemiological studies have found that acute social anxiety is the third most common psychiatric disorder in the United States………. affecting up to 13 percent of Americans. Jerilyn Ross, president of the Anxiety Disorders Association of America……she hopes a publicity blitz planned by………..SmithKline Beecham will raise awareness of social anxiety disorder and lead more people to seek help, which could include psychotherapy instead of drugs.” Why were the Boston Globe and the New York Times both writing about “social phobia disorder” in the same week, and why would a drug company spend its money to “raise awareness” of a mental-health disorder? The answer: the FDA had just approved a drug for the treatment of social phobia. As the Boston Globe put it, SmithKline Beecham makes the drug Paxil, which was “the first drug approved by the FDA specifically for treating social anxiety disorder.”

Continue reading

‘Shut Up and Pass the Prozac’ – Top Psychiatrist, Pro-Family Advocates Left Out of National Debate on Mental Health

By Debbie Thurman, Christian Communication Network

MONROE, Va., July 18 /Christian Wire Service/– “Shut up and pass the Prozac.” That is the consensus of the media in the most volatile round of psycho trash talk in recent memory. Since Tom Cruise kicked it up a notch on the “Today” show with Matt Lauer, all manner of “experts” have weighed in on both sides of the debate.

One of the most articulate and credentialed critics of current psychiatric practices was notably absent, however. Dr. Peter Breggin of The International Center for the Study of Psychiatry and Psychology, was essentially shut out of the debate by the media, at one point being forced to watch a 90-minute-long exchange between Jane Pauley and CNBC’s Donny Deutche, which he was invited to join by link-up, but to which he was never asked to contribute a comment.

Continue reading

Arianna’s Call For Drug-Violence Investigation Never More Timely

By Kelly Preston

Kirstie Alley and I recently supported 20 doctors from various health care fields, including family physicians, pediatricians, psychiatrists, researchers, nutritionists and surgeons in a letter to the FDA calling on it to strengthen its warnings on stimulants and antidepressants, especially when prescribed to children.

This was in response to the FDA’s recent warning that not only do antidepressants cause hostility and suicidal behavior in children, but also stimulant drugs [June 28 FDA advisory]. The doctors’ letter states: “We can no longer sit back and let the clock tick, waiting for more deaths, suicides or people driven to violent acts by psychotropic drugs. The FDA must continue to be vigilant, to root out other substances that have — one way or the other — slipped under the radar screen, and are now wreaking havoc with the nation’s youth.”

Continue reading

AstraZeneca Drug Raises Diabetes Risk, Doctor Says

Bloomberg News
By Sophia Pearson and Doris Bloodsworth
Jan. 16, 2008

AstraZeneca Plc’s antipsychotic drug Seroquel raised by almost 400 percent the risk of developing diabetes when compared with first-generation medications in its class, a doctor testified in a court case against the drugmaker.

A 2004 article published in Psychiatric Services, a journal of the American Psychiatric Association, reported the increased risk in males who were exposed to Seroquel for at least 60 days. The study, which involved 1,629 patients, compared the exposure of a newer class of antipsychotics including clozapine and Seroquel with an older class of drugs, Jennifer Marks, a Miami- based endocrinologist, said during a pre-trial hearing yesterday in federal court in Orlando, Florida.

“Seroquel is a substantial factor in diabetes and weight gain,” Marks said, noting the 389 percent rise.

AstraZeneca, the U.K.’s second-largest drugmaker, faces about 9,000 lawsuits in the U.S. over claims Seroquel causes diabetes and other health problems. Seroquel, which generated sales of $4.03 billion in 2007, is the London-based company’s second-biggest seller after the ulcer treatment Nexium. Marks testified on behalf of former Seroquel user Linda Guinn, the first case to come to trial over the drug.

More here:

28,093 Signatures Against TeenScreen. Petition: